Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
about
AR Signaling in Breast Cancer.Targeting the androgen receptor in triple-negative breast cancer: current perspectives.Structure-Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells.Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway.The Androgen Receptor in Breast CancerThe "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
P2860
Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective activity of deguelin ...... ceptor-positive breast cancer.
@en
Selective activity of deguelin ...... ceptor-positive breast cancer.
@nl
type
label
Selective activity of deguelin ...... ceptor-positive breast cancer.
@en
Selective activity of deguelin ...... ceptor-positive breast cancer.
@nl
prefLabel
Selective activity of deguelin ...... ceptor-positive breast cancer.
@en
Selective activity of deguelin ...... ceptor-positive breast cancer.
@nl
P2093
P2860
P1476
Selective activity of deguelin ...... ceptor-positive breast cancer.
@en
P2093
Andrew J Robles
Robert H Cichewicz
Shengxin Cai
Susan L Mooberry
P2860
P2888
P304
P356
10.1007/S10549-016-3841-9
P407
P577
2016-06-02T00:00:00Z